Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx

NCT01020097 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: fluorine F18 EF5
PROCEDURE: immunohistochemistry staining method
PROCEDURE: biopsy
PROCEDURE: Positron Emission tomography

Sponsor

Abramson Cancer Center at Penn Medicine